Last reviewed · How we verify

NCT04817748: MCBDTMIDT

Metabolomics Characterization of Biomarkers of Different Types of Myocardial Infarction in Different Time.

Status unknown Last updated 26 March 2021
What this trial tests

trial in Myocardial Infarction in 40 participants. Status unknown.

Timeline
17 November 2020
Primary endpoint
1 May 2021
1 May 2021

Quick facts

Lead sponsorShanghai 10th People's Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date17 November 2020
Primary completion1 May 2021
Estimated completion1 May 2021
Sites1 location across China

Conditions studied

Sponsor

Shanghai 10th People's Hospital

Who can join

Adults 20 to 76, any sex, with Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To find new biomarkers through Metabonomics Study of different types of myocardial infarction in Different Time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

Other Shanghai 10th People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04817748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing